DK145377C - Analogifremgangsmaade til fremstilling af n-(2'-pyrrolidinylmethyl)benzamider eller syreadditionssalte eller kvaternaere ammoniumsalte eller optisk aktive isomere deraf - Google Patents
Analogifremgangsmaade til fremstilling af n-(2'-pyrrolidinylmethyl)benzamider eller syreadditionssalte eller kvaternaere ammoniumsalte eller optisk aktive isomere derafInfo
- Publication number
- DK145377C DK145377C DK86975A DK86975A DK145377C DK 145377 C DK145377 C DK 145377C DK 86975 A DK86975 A DK 86975A DK 86975 A DK86975 A DK 86975A DK 145377 C DK145377 C DK 145377C
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidinylmethyl
- benzamides
- analogue
- preparation
- quaternary ammonium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7407535 | 1974-03-05 | ||
| FR7407535A FR2262966A1 (en) | 1974-03-05 | 1974-03-05 | N-(2-azacycloalkyl-alkyl)-benzamide derivs. - with antiemetic, antiulcer and CNS activity |
| FR7503800A FR2299863B1 (fr) | 1975-02-07 | 1975-02-07 | Nouveaux N-(Z-pyrrolidiny alkyl) benzamides substitués, leurs dérivés et leur procédé de préparation |
| FR7503800 | 1975-02-07 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK86975A DK86975A (da) | 1975-11-03 |
| DK145377B DK145377B (da) | 1982-11-08 |
| DK145377C true DK145377C (da) | 1983-04-11 |
Family
ID=26218210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK86975A DK145377C (da) | 1974-03-05 | 1975-03-04 | Analogifremgangsmaade til fremstilling af n-(2'-pyrrolidinylmethyl)benzamider eller syreadditionssalte eller kvaternaere ammoniumsalte eller optisk aktive isomere deraf |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS6015616B2 (da) |
| AR (1) | AR206621A1 (da) |
| AT (1) | AT358570B (da) |
| BG (1) | BG24666A3 (da) |
| CA (1) | CA1047504A (da) |
| CH (1) | CH605794A5 (da) |
| CS (1) | CS189692B2 (da) |
| DD (1) | DD119420A5 (da) |
| DE (1) | DE2507989A1 (da) |
| DK (1) | DK145377C (da) |
| EG (1) | EG12577A (da) |
| ES (1) | ES435274A1 (da) |
| FI (1) | FI750620A (da) |
| GB (1) | GB1466822A (da) |
| HK (1) | HK14078A (da) |
| HU (1) | HU170637B (da) |
| IE (1) | IE40818B1 (da) |
| IL (1) | IL46696A (da) |
| LU (1) | LU71949A1 (da) |
| NL (1) | NL7502608A (da) |
| NO (1) | NO750713L (da) |
| OA (1) | OA04966A (da) |
| PH (1) | PH14197A (da) |
| PL (1) | PL97091B1 (da) |
| RO (2) | RO70647A (da) |
| SE (1) | SE411754B (da) |
| SU (1) | SU609464A3 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ186175A (en) * | 1977-01-27 | 1980-03-05 | Shionogi & Co | Meta-sulphonamidobenzamide derivatives |
| SE8503054D0 (sv) * | 1985-06-19 | 1985-06-19 | Astra Laekemedel Ab | Catecholcarboxamides |
| US4772459A (en) * | 1986-09-09 | 1988-09-20 | Erbamont, Inc. | Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
| EP0314483A1 (en) * | 1987-10-29 | 1989-05-03 | Erbamont, Inc. | Preparation of benzamides |
| FR2699533A1 (fr) * | 1992-12-21 | 1994-06-24 | Mouhtaram Mohamed | Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3078497A (en) * | 1960-12-29 | 1963-02-26 | Leeds And Mieallef | Dispensing containers |
-
1975
- 1975-02-24 IL IL46696A patent/IL46696A/xx unknown
- 1975-02-25 DE DE19752507989 patent/DE2507989A1/de not_active Withdrawn
- 1975-02-26 GB GB809575A patent/GB1466822A/en not_active Expired
- 1975-03-03 AT AT160775A patent/AT358570B/de not_active IP Right Cessation
- 1975-03-03 SE SE7502342A patent/SE411754B/xx not_active IP Right Cessation
- 1975-03-03 LU LU71949A patent/LU71949A1/xx unknown
- 1975-03-03 EG EG109/75A patent/EG12577A/xx active
- 1975-03-04 CA CA221,240A patent/CA1047504A/en not_active Expired
- 1975-03-04 FI FI750620A patent/FI750620A/fi not_active Application Discontinuation
- 1975-03-04 ES ES435274A patent/ES435274A1/es not_active Expired
- 1975-03-04 CS CS751445A patent/CS189692B2/cs unknown
- 1975-03-04 DK DK86975A patent/DK145377C/da active
- 1975-03-04 NO NO750713A patent/NO750713L/no unknown
- 1975-03-04 IE IE457/75A patent/IE40818B1/xx unknown
- 1975-03-04 SU SU2112487A patent/SU609464A3/ru active
- 1975-03-04 BG BG7500029148A patent/BG24666A3/xx unknown
- 1975-03-04 HU HUSO1137A patent/HU170637B/hu not_active IP Right Cessation
- 1975-03-04 OA OA55430A patent/OA04966A/xx unknown
- 1975-03-05 CH CH279975A patent/CH605794A5/xx not_active IP Right Cessation
- 1975-03-05 NL NL7502608A patent/NL7502608A/xx not_active Application Discontinuation
- 1975-03-05 RO RO7588831A patent/RO70647A/ro unknown
- 1975-03-05 JP JP50027573A patent/JPS6015616B2/ja not_active Expired
- 1975-03-05 RO RO7581558A patent/RO72844A/ro unknown
- 1975-03-05 DD DD184579A patent/DD119420A5/xx unknown
- 1975-03-05 PL PL1975178533A patent/PL97091B1/pl unknown
- 1975-04-04 AR AR257837A patent/AR206621A1/es active
-
1977
- 1977-08-22 PH PH20152A patent/PH14197A/en unknown
-
1978
- 1978-03-16 HK HK140/78A patent/HK14078A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL97091B1 (pl) | 1978-02-28 |
| AT358570B (de) | 1980-09-25 |
| PH14197A (en) | 1981-03-26 |
| DE2507989A1 (de) | 1975-09-11 |
| SU609464A1 (da) | 1978-05-30 |
| ATA160775A (de) | 1980-02-15 |
| AR206621A1 (es) | 1976-08-06 |
| JPS6015616B2 (ja) | 1985-04-20 |
| NO750713L (da) | 1975-09-08 |
| SU609464A3 (ru) | 1978-05-30 |
| DK145377B (da) | 1982-11-08 |
| GB1466822A (en) | 1977-03-09 |
| IL46696A (en) | 1978-07-31 |
| HK14078A (en) | 1978-03-23 |
| OA04966A (fr) | 1980-10-31 |
| BG24666A3 (en) | 1978-04-12 |
| IE40818B1 (en) | 1979-08-29 |
| SE7502342L (da) | 1975-09-08 |
| DK86975A (da) | 1975-11-03 |
| AU7874075A (en) | 1976-09-09 |
| RO72844A (ro) | 1981-09-24 |
| IE40818L (en) | 1975-09-05 |
| JPS50123668A (da) | 1975-09-29 |
| ES435274A1 (es) | 1976-12-16 |
| CA1047504A (en) | 1979-01-30 |
| SE411754B (sv) | 1980-02-04 |
| CS189692B2 (en) | 1979-04-30 |
| CH605794A5 (da) | 1978-10-13 |
| NL7502608A (nl) | 1975-09-09 |
| DD119420A5 (da) | 1976-04-20 |
| EG12577A (en) | 1979-09-30 |
| FI750620A (da) | 1975-09-06 |
| IL46696A0 (en) | 1975-04-25 |
| LU71949A1 (da) | 1976-02-04 |
| RO70647A (ro) | 1980-04-15 |
| HU170637B (da) | 1977-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK145376C (da) | Analogifremgangsmaade til fremstilling af n-(1'-benzyl-2'-pyrrolidinylmethyl)-benzamider eller syreadditionssalte,kvaternaere ammoniumsalte eller optisk aktive isomere deraf | |
| DK145119C (da) | Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf | |
| DK143275C (da) | Analogifremgangsmaade til fremstilling af 1-(3-dimethylaminopropyl)-phthalanderivater eller syreadditionssalte deraf | |
| DK162714C (da) | Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf | |
| DK178379A (da) | Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf | |
| DK147421C (da) | Analogifremgangsmaade til fremstilling af piperazinderivater eller syreadditionssalte eller kvaternaere ammoniumsalte deraf | |
| DK145260C (da) | Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf | |
| DK148904C (da) | Analogifremgangsmaade til fremstilling af analgetisk virksomme enkephalin-analoge pentapeptidamider eller farmaceutisk acceptable, ikke-toxiske syreadditionssalte deraf | |
| DK160045C (da) | Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf | |
| DK146245C (da) | Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive azabicycloforbindelser eller syreadditionssalte deraf | |
| DK156301C (da) | Analogifremgangsmaade til fremstilling af oxy- eller oxosubstituerede phenoxy- eller phenylthio-azacycloalkaner eller deres syreadditionssalte | |
| DK145019C (da) | Analogifremgangsmaade til fremstilling af (3,5-diamino-6-fluorpyrazinoyl)guanidin eller syreadditionssalte deraf | |
| DK149231C (da) | Analogifremgangsmaade til fremstilling af enkephalin-analoge tetrapeptidamider eller syreadditionssalte deraf | |
| DK135842C (da) | Analogifremgangsmade til fremstilling af 7-methoxy-6-thiatetracycliner eller syreadditionssalte deraf | |
| DK142544C (da) | Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf | |
| DK143278C (da) | Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf | |
| DK155672C (da) | Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte eller optisk aktive isomerer deraf | |
| DK146066C (da) | Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf | |
| DK312477A (da) | Fremgangsmade til fremstilling af basisk substituerede phenylacetonitriler eller syreadditionssalte deraf | |
| DK145377C (da) | Analogifremgangsmaade til fremstilling af n-(2'-pyrrolidinylmethyl)benzamider eller syreadditionssalte eller kvaternaere ammoniumsalte eller optisk aktive isomere deraf | |
| DK154083C (da) | Analogifremgangsmaade til fremstilling af halogenvincamonderivater eller optisk aktive isomere eller syreadditionssalte deraf | |
| DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK156068C (da) | Analogifremgangsmaade til fremstilling af n-(2-methoxyethyl)-noroxymorphon eller syreadditionssalte deraf | |
| DK147577C (da) | Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160874C (da) | Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |